If you or someone you care about is struggling with opioid use disorder, you’ve probably wondered if medicated treatment is a good option. In these conversations, two names usually come up: Suboxone and methadone. Both have helped millions of people recover from opioid addiction, and both are approved by the FDA for treating opioid use disorder. But they work differently, they’re prescribed differently, and choosing between them depends on your individual circumstances.
This guide breaks down the key differences between Suboxone and methadone so you can have an informed conversation with your treatment provider about which option might work best for you.
What Are Suboxone and Methadone?
Both Suboxone and methadone are medications used in what’s called medication-assisted treatment, or MAT. MAT combines FDA-approved medications with counseling and behavioral therapies to treat opioid use disorder. The medications reduce withdrawal symptoms and cravings, which allows people to focus on recovery without the constant physical pull toward opioid use.
Methadone has been used to treat opioid addiction since the 1960s. It’s a full opioid agonist, meaning it fully activates the opioid receptors in your brain. However, because it activates these receptors more slowly than heroin or fentanyl, it doesn’t produce the same intense high. It stays in your body longer, too, which means it can prevent withdrawal symptoms for 24 to 36 hours.
Suboxone is newer, approved for opioid use disorder treatment in 2002. It contains two active ingredients: buprenorphine and naloxone. Buprenorphine is a partial opioid agonist, meaning it activates opioid receptors in your brain, but only partially. This partial activation provides enough effect to reduce cravings and withdrawal symptoms without producing the full opioid high. Naloxone is added to discourage misuse. If someone tries to inject Suboxone, the naloxone triggers withdrawal symptoms instead of any pleasurable effect.
How They Work Differently in Your Brain
The distinction between full agonist and partial agonist matters more than it might seem at first glance.
Methadone, as a full agonist, has no built-in limit on its effects. Higher doses produce stronger effects. This makes it highly effective at blocking withdrawal symptoms and cravings, particularly for people with severe or long-standing opioid dependence. But it also means there’s a real risk of overdose if someone takes too much, especially during the first few weeks of treatment before their body has adjusted to the medication.
Buprenorphine, the active ingredient in Suboxone, has what pharmacologists call a “ceiling effect.” After a certain dose, taking more doesn’t increase the medication’s effects. Your brain’s opioid receptors are already as activated as buprenorphine can make them. This ceiling effect is one of the main safety advantages of Suboxone. Respiratory depression, the primary cause of death in opioid overdoses, levels off at higher doses rather than continuing to increase. According to research published in the National Institutes of Health database, this makes buprenorphine safer in overdose situations than methadone or other full opioid agonists.
That said, buprenorphine can still be dangerous when combined with other central nervous system depressants like alcohol, benzodiazepines, or sedatives. The ceiling effect protects against buprenorphine overdose alone, but mixing it with other substances can still lead to respiratory depression and death.
How Treatment Looks Day to Day
One of the biggest practical differences between Suboxone and methadone is how you receive the medication.
Methadone for opioid use disorder treatment must be dispensed through federally approved opioid treatment programs, commonly called methadone clinics. When you start treatment, you’ll need to visit the clinic daily to receive your dose under supervision. For many people, this means showing up every morning before work or other responsibilities. Over time, as you demonstrate stability in your recovery, you may earn “take-home” privileges. Federal regulations now allow programs to provide up to 28 doses of methadone for patients to take home, though individual programs and states may have stricter policies.
Suboxone can be prescribed by doctors, nurse practitioners, and physician assistants in regular outpatient settings. You don’t need to visit a specialized clinic. Your prescriber can write a prescription that you fill at a regular pharmacy, and you take your medication at home. Since the COVID-19 pandemic, prescribers can even start patients on buprenorphine through telehealth appointments in many cases.
This accessibility is one of Suboxone’s major advantages. For people in rural areas without nearby methadone clinics, for those whose work schedules don’t allow daily clinic visits, or for anyone who values privacy in their treatment, the ability to receive a prescription and take medication at home makes a significant difference.
Which Medication Is More Effective?
Both medications work. Research consistently shows that methadone and buprenorphine reduce opioid use, decrease overdose deaths, lower rates of infectious disease transmission, and help people stay in treatment longer than behavioral interventions alone.
A landmark study funded by the National Institutes of Health examined outcomes among more than 17,000 adults in Massachusetts who survived an opioid overdose. Compared to those who received no medication-assisted treatment, opioid overdose deaths decreased by 59 percent for those receiving methadone and 38 percent for those receiving buprenorphine over the following 12 months. Both medications saved lives, though methadone showed a somewhat larger effect in this particular population.
Some research suggests methadone may have a slight edge in treatment retention, meaning patients are somewhat more likely to stay in treatment over time. This may be partly because the daily clinic visits required for methadone create built-in accountability and regular contact with treatment staff. It may also reflect the fact that methadone, as a full agonist, can provide stronger relief from cravings for people with more severe opioid dependence.
However, head-to-head studies have shown mixed results, and the differences in effectiveness tend to be modest. The American Society of Addiction Medicine and other professional organizations consider both medications to be appropriate first-line treatments for opioid use disorder. The choice often comes down to individual factors: your history of opioid use, your living situation, your work schedule, and your own preferences.
Who Is Each Medication Best Suited For?
Methadone may be a better choice for people with severe, long-standing opioid dependence, particularly those who have used high doses of opioids like fentanyl. Because it’s a full agonist without a ceiling effect, methadone can provide stronger relief from withdrawal symptoms and cravings at higher doses. Some patients who don’t achieve adequate symptom control on buprenorphine do better on methadone.
Methadone also has a longer track record. It’s been the standard of care for pregnant women with opioid use disorder, though research increasingly supports buprenorphine during pregnancy as well. Both medications are safer for the fetus than continued opioid use, and both can result in neonatal abstinence syndrome, though some studies suggest buprenorphine may cause milder withdrawal symptoms in newborns.
Suboxone tends to work well for people with mild to moderate opioid use disorder, or for those who need the flexibility of taking medication at home. The ceiling effect makes it safer for patients who might be at higher risk of taking extra doses. The ability to receive prescriptions in ordinary medical settings makes it more accessible for people who can’t get to a methadone clinic daily.
Suboxone is also often easier to discontinue when patients are ready. Withdrawal symptoms when stopping buprenorphine tend to be milder than those associated with methadone discontinuation, partly because of buprenorphine’s partial agonist properties and different binding characteristics at opioid receptors.
Side Effects and Safety Considerations
Both medications have side effects typical of opioids, including constipation, drowsiness, nausea, and sweating. Most side effects diminish over time as your body adjusts to the medication.
Methadone carries some specific risks worth knowing about. It can prolong the QT interval in your heart’s electrical activity, which in rare cases can lead to dangerous heart rhythm problems. This risk is higher at doses above 120 mg daily or in people taking other medications that affect heart rhythm. Methadone clinics typically monitor for this with periodic EKGs.
The overdose risk with methadone is highest in the first few weeks of treatment, before the medication reaches a stable level in your body. During this period, the clinic adjusts your dose carefully, watching for signs that the dose is too high.
Suboxone’s main safety advantage is the ceiling effect discussed earlier. But there’s one important caution: if you’re currently taking opioids and haven’t yet gone into withdrawal, starting Suboxone can trigger what’s called “precipitated withdrawal.” Because buprenorphine has such high affinity for opioid receptors, it displaces other opioids from those receptors but doesn’t activate them as strongly. The result is sudden, intense withdrawal symptoms. To avoid this, you typically need to wait until you’re already in early withdrawal before taking your first Suboxone dose, usually 12 to 24 hours after your last opioid use, or longer if you’ve been using fentanyl.
Cost and Insurance Coverage in Maine
Both methadone and Suboxone are typically covered by insurance, including MaineCare (Maine’s Medicaid program). Under federal and state mental health parity laws, insurance companies generally must cover medication-assisted treatment for opioid use disorder the same way they cover treatment for other medical conditions.
Out-of-pocket costs vary depending on your insurance plan. Generic buprenorphine is available and tends to be less expensive than brand-name Suboxone. Methadone itself is inexpensive, but the cost of daily clinic visits can add up if you’re paying out of pocket.
If you don’t have insurance, many treatment programs offer sliding scale fees or can help you apply for MaineCare. The Maine Office of Behavioral Health oversees substance use disorder treatment services across the state and can help connect you with resources.
Maine Resources for Opioid Use Disorder Treatment
Maine offers several types of medication-assisted treatment. Certified opioid treatment programs provide methadone and buprenorphine under close medical supervision with required counseling. Office-based opioid treatment (OBOT) programs provide buprenorphine through outpatient medical or behavioral health settings. Both options are available throughout the state.
The Maine DHHS Office of Behavioral Health maintains a directory of licensed treatment providers. You can also call 211 Maine or visit 211maine.org for help finding treatment options in your area. Maine’s toll-free Opioid Helpline, operated in partnership with DHHS, connects callers with specialists who can identify treatment options and resources based on your location and needs.
For immediate crisis support, the Maine Crisis Line is available 24/7 at 888-568-1112. You can call, text, or chat with trained professionals who can help during moments of acute distress.
Medication-Assisted Treatment at ENSO Recovery
ENSO Recovery provides comprehensive medication-assisted treatment at our outpatient centers in Augusta and Sanford, Maine. Our MAT program uses medications including Suboxone and Vivitrol to help patients manage withdrawal symptoms, reduce cravings, and build a stable foundation for recovery.
We believe medication is most effective when combined with therapy and support services. Our Augusta location and Sanford location both offer intensive outpatient programs that combine group therapy and life skills training with medication management. Individual counseling, mental health services, and case management are also available.
ENSO Recovery was the first substance use treatment program to offer MAT in Maine county jails, and we continue to serve post-release individuals as well as community members seeking treatment. We operate recovery residences certified by the Maine Association of Recovery Residences, and all of our houses accept individuals on MAT. This means you can receive medication-assisted treatment while living in a supportive, structured environment focused on recovery.
Our team includes experienced providers and compassionate staff who understand what you’re going through. Many of us have personal connections to addiction and recovery. We approach every patient with respect, without judgment, and with a genuine commitment to helping you succeed.
Taking the First Step
Choosing between Suboxone and methadone isn’t a decision you need to make alone. A treatment provider can assess your situation, discuss your history with opioids, consider your practical circumstances, and help you weigh the options.
What matters most is starting treatment. Both medications dramatically reduce the risk of overdose death compared to no treatment at all. Both give your brain and body time to heal while you do the harder work of building a life in recovery.
If you’re ready to take that step, ENSO Recovery is here. Our recovery specialists are available for outpatient care Monday through Friday, 8 a.m. to 4:30 p.m. Call (207) 245-1800 to schedule an appointment at our Augusta or Sanford location. You can also contact us online and we’ll reach out to you.
Crisis Resources
If you or someone you know is in crisis, please reach out for help. The 988 Suicide and Crisis Lifeline is available 24/7 by calling or texting 988. For medical emergencies, call 911.
Learn More
Medications for Opioid Use Disorder – National Institute on Drug Abuse
What Is Buprenorphine? – Substance Abuse and Mental Health Services Administration
Information About Medications for Opioid Use Disorder – U.S. Food and Drug Administration
Substance Use Disorder Treatment – Maine Department of Health and Human Services
Maine Addiction Treatment and Substance Use Resources – 211 Maine